Skip directly to site content Skip directly to search


Español  Other Languages


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
 Search
		×
			Vaccines site
			Vaccines site
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


Immunization Information Systems (IIS)








Vaccine 2D Barcoding for Manufacturers						Print
																Related Pages
										View which manufacturers have added 2D barcodes to the UoU in the List of Vaccines Shipping with 2D Barcodes.
Vaccine manufacturers play a key role in affixing 2D barcodes on vaccine products. The Drug Supply Chain Security Act, enacted in 2013, mandated 2D barcodes on the secondary packaging, or unit of sale (UoS). An increasing number of manufacturers have added 2D barcodes to the unit of use (UoU) packaging (e.g., vials, syringes) for the purpose of scanning upon vaccine administration as well.
The following resources discuss the implications, opportunities, and challenges of implementing 2D barcode technology on vaccine products and provide guidance on requirements and general specifications to-date. Also included is historical information on the 2012 CDC Vaccine Manufacturers Forum.
2D Barcode Resources
AAP and GS1 Guidance for Manufacturers and Suppliers (GS1R DataMatrix Barcodes to Vaccines for Point of Care) [25 pages]
This “Application Guideline” developed in collaboration between the American Academy of Pediatrics (AAP) and GS1 Healthcare US, a barcode standards development organization, provides specification for creating GS1 DataMatrix 2D barcodes at the point-of-care or primary vaccine package.
Guidance for Industry: Bar Code Label Requirements – Questions and Answers [14 pages], August 2011
This guidance from the Food and Drug Administration (FDA) provides questions and answers relating to how the bar code label requirements apply to specific products or circumstances. This guidance finalizes the draft guidance entitled “Guidance for Industry: Bar Code Label Requirements – Questions and Answers (Question 12 Update)” dated August 2010, and supersedes the guidance entitled “Guidance for Industry: Bar Code Label Requirements – Questions and Answers” dated October 2006.
GS1 General Specifications [6.18 MB, 478 pages], Release 20.0, Ratified, Jan 2020
The foundational GS1 standard that defines how identification keys, data attributes and 2D and other barcodes must be used in business applications.
GS1 Healthcare GTIN Allocation Rules [1.1 MB, 26 pages], Release 10.0, Ratified, Jun 2020
Includes information on the Global Trade Item Number (GTIN) Allocation Rules for the Healthcare Sector.Description and Benefits of 2D Barcodes and Scanning during Mass Vaccinations
This one-page brief [1 page] provides a description of vaccine 2D barcodes and the benefits of scanning them during mass vaccinations.
A Brief on Different Vaccine Lot Numbers on Unit of Sale (package) and Unit of Use (vial/syringe)
This two-page brief [2 pages]describes the background and challenges of different vaccine lot numbers on the unit of sale vaccine product (package or salable box) and the unit of use vaccine product (e.g., vial, syringe). The brief includes current tools, ongoing efforts, and plans to update information related to this issue.
The Drug Supply Chain Security Act and 2D Vaccine Barcodes
The Drug Supply Chain Security Act and 2D Vaccine Barcodes [15 pages] report evaluates the Drug Supply Chain Security Act (DSCSA) from the perspective of vaccine 2D barcode scanning. This law aims to enhance the FDA’s ability to protect consumers by identifying and removing counterfeit and dangerous medicines/products from the U.S. pharmaceutical supply chains and calls for the implementation of an electronic, interoperable system by 2023. More information about this law is available at the FDA web site.
Vaccine Manufacturers Forum
Description
On January 26, 2012 CDC held a 2D Barcode Vaccine Manufacturers Forum to engage the vaccine manufacturing community. It included vaccine product manufacturers, their distributors, and trading partners in presentations and discussions on the implications, opportunities, and challenges of implementing 2D barcoding technology on vaccine products.
It was attended by over 60 industry stakeholders including 26 representatives from 10 vaccine manufacturing companies. In addition to the manufacturers, the Forum was attended by representatives of retail pharmacy supply chains, standards organizations, and trade associations. Regulatory and global agencies including World Health Organization (WHO), the Food and Drug Administration (FDA), and CDC participated in the event, providing a unique opportunity for the industry and regulators to connect and discuss the changing requirements and standards for vaccines.
Speakers discussed implementation issues and standards related to 2D barcoding technology for vaccine products. A working session during the forum divided attendees into smaller groups to discuss topics related to opportunities and challenges regarding 2D barcode implementation.
Objectives
The goals and objectives of the Forum were:
Engage the vaccine manufacturing community in the discussion of the benefits, impacts, and challenges of implementing 2D barcoding.
Understand the regulations and standards landscape in more detail.
Explore the options and considerations for moving the industry forward toward the implementation of 2D barcoding of vaccine products.Reports
Two-Dimensional (2D) Vaccine Barcoding Manufacturers Forum Final Report [32 pages]
CDC 2D Vaccine Barcode Pilot-Manufacturers Forum Outcome [2 pages]Top of Page
Related Page
List of Vaccines Shipping with 2D Barcodes
							
					
							Last Reviewed:  January 19, 2021						Source: 	National Center for Immunization and Respiratory Diseases
					Facebook
        Twitter
        LinkedIn
        Syndicate homeIIS Home
About IIS
Functional Standardsplus icon
Version 4.1
Core Data Elementsplus icon
Core Data Elements For IIS Functional Standards v4.0
Historical Core Data Elements
Data Code Setsplus icon
CVX
CVX Mapped to Vaccine Groups
CVX Mapped to VIS
MVX
Product Name Mapped to CVX/MVX
NDC Crosswalk Tables
VIS Barcode Lookup Table
VIS URL Table
CPT Mapped to CVX
Fall Season Respiratory Vaccine Codes
IIS Technical Guidanceplus icon
HL7
Transport (SOAP)
Deduplication
Clinical Decision Support for Immunization (CDSi)plus icon
CDSi Training Material
IZ Gatewayplus icon
Overview
Information Sheet
Awardee Forum Q&As
Meaningful Use
Vaccine 2D Barcodesplus icon
Vaccine 2D Barcoding for Manufacturers
Vaccines Shipping with 2D Barcodes
Vaccine 2D Barcode Scanning for Vendors
Vaccine 2D Barcode Scanning Initiatives
Vaccine 2D Barcode Scanning Implementation Toolkit
CDC IIS Activitiesplus icon
MIROW
NIS-IIS Collaboration
Sentinel Sites
IIS Strategic Planplus icon
2018-2020
2014-2017
Contacts for IIS Immunization Records
IIS Policy and Legislation
IIS Annual Report (IISAR)plus icon
Overview
Participation Rates and Maps
MMWR Articles on Annual Report Data
IISAR Survey Data
IIS Training
Resources & Reference Materialsplus icon
Acronyms
Conferences & Events
Frequently Asked Questions
Functional Standards Resource Guide
Partner Organizations
Publications
Sustainability Resources National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
1600 Clifton Road NE, Building 24
Mailstop A-19
Atlanta, GA 30333
iisinfo@cdc.gov
 Vaccines & ImmunizationsCDC Meaningful UseVaccine Tracking System (VTrckS)Vaccines for Children Program (VFC)Vaccine Management Business Improvement Project (VMBIP)Comprehensive Clinic Assessment Software Application (CoCASA)


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue